|Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse|
Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP
|Release Date: December 06, 2018|
Expiration Date: December 06, 2019
|New and emerging therapies are changing the treatment paradigms and care of patients with newly diagnosed advanced Hodgkin lymphoma. This symposium replay takes a closer look at these changes and their impact to nursing care. Our presenters provide an overview of the therapeutic treatment options and their known side-effect profiles which, if left unmanaged, could impact the overall progress and quality of life for patients. This activity includes presentations from our expert faculty on best strategies to employ in recognizing, treating, and long-term management of adverse events. We encourage you to listen in as faculty discuss the day-to-day educational needs of patients being treated for cHL.|
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Seattle Genetics, Inc.
|Begin, Earn CreditView Only, No Credit|